Target intelligence / Profile preview

GALNT16 and EXD2 antisense RNA 1 (GALNT16-AS1)

Target
GALNT16-AS1
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

GALNT16 and EXD2 antisense RNA 1 (GALNT16-AS1) is a long non-coding RNA gene transcribed from chromosome 14 on the reverse strand[1]. Antisense RNAs are regulatory molecules that modulate the expression of neighboring or overlapping genes through various mechanisms, including interference with transcription, epigenetic modification, or mRNA stability[2]. There is currently no evidence for GALNT16-AS1 as a therapeutic target or involvement in specific diseases, nor any documented interactions with drugs or function as a biomarker. Its biological relevance likely resides in local gene regulation, potentially affecting expression of adjacent genes such as GALNT16 or EXD2, but experimental data for its specific function is not yet available[1][2].

02

Mechanism of action

Not applicable; no targeted drugs known for GALNT16-AS1. Mechanistically, antisense RNAs typically regulate gene expression via transcriptional interference, chromatin modification, or mRNA stability[2].

03

Biological functions

Regulation of gene expression

Beyond the preview

Go deeper on GALNT16 and EXD2 antisense RNA 1 (GALNT16-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GALNT16 and EXD2 antisense RNA 1 (GALNT16-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call